Sanofi
SNY
487 hedge funds and large institutions have $8.52B invested in Sanofi in 2018 Q1 according to their latest regulatory filings, with 53 funds opening new positions, 156 increasing their positions, 182 reducing their positions, and 67 closing their positions.
165% more call options, than puts
Call options by funds: $56.6M | Put options by funds: $21.3M
0.91% less ownership
Funds ownership: 17.86% → 16.96% (-0.91%)
3% less funds holding
Funds holding: 504 → 487 (-17)
13% less capital invested
Capital invested by funds: $9.77B → $8.52B (-$1.24B)
14% less repeat investments, than reductions
Existing positions increased: 156 | Existing positions reduced: 182
21% less first-time investments, than exits
New positions opened: 53 | Existing positions closed: 67
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fisher Asset Management
Camas,
Washington
|
+$23.8M |
| 2 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$22.8M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$22M |
| 4 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$20.3M |
| 5 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$19.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Boston Partners
Boston,
Massachusetts
|
-$364M |
| 2 |
SCA
Southpoint Capital Advisors
New York
|
-$94.6M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$69.4M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$66.2M |
| 5 |
AWE
Avidian Wealth Enterprises
Houston,
Texas
|
-$59M |
SNY Hedge Fund Activity: Q1 2018 in Review
487 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q1 2018, worth a combined $8.52B — down 13% from $9.77B a quarter earlier.
Sellers outnumbered buyers: 67 funds closed out of SNY and 53 opened new positions — a net loss of 14 holders — while 182 trimmed existing stakes and 156 added.
The largest buyer was Fisher Asset Management, adding an estimated $23.8M. The largest seller was Boston Partners, exiting entirely with an estimated $364M sold.
- 487 institutional investors held Sanofi (SNY) as of Q1 2018, down from 504 in Q4 2017.
- Funds reported $8.52B of Sanofi stock for Q1 2018, down 13% quarter-over-quarter.
- 53 funds opened new Sanofi positions in Q1 2018 and 67 closed out, a net change of -14 holders.
- The largest Sanofi buyer in Q1 2018 was Fisher Asset Management, an estimated $23.8M added.
- The largest Sanofi seller in Q1 2018 was Boston Partners, an estimated $364M sold.
Based on aggregated 13F filings for Q1 2018.